` 380550 (Neurophet Inc) vs KOSPI 200 Comparison - Alpha Spread

N
380550
vs
K
KOSPI 200

Over the past 12 months, Neurophet Inc has underperformed KOSPI 200, delivering a return of -14% compared to KOSPI 200's +116% growth.

Stocks Performance
380550 vs KOSPI 200

Loading...
380550
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
380550 vs KOSPI 200

Performance Gap Between 380550 and KOSPI200
LOCKED
Unlock

Performance By Year
380550 vs KOSPI 200

Loading...
380550
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Neurophet Inc vs Peers

KOSPI 200
380550
VEEV
PME
2413
SECT B
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Neurophet Inc
Glance View

Market Cap
99.7B KRW
Industry
Health Care

Neurophet, Inc. engages in the development of advanced neuroscience technologies. The company is headquartered in Seoul, Seoul. The company went IPO on 2025-07-25. The firm is mainly engaged in the development and sale of positron emission tomography (PET) image quantitative analysis software ‘Neurophet SCALE PET’, neurodegenerative brain disease diagnosis support software ‘Neurophet AQUA’, as well as Alzheimer’s disease imaging biomarker solution 'Neurophet AQUA AD' and other products. The firm is also engaged in the development and sale of therapeutic medical devices. In addition, the Company provides clinical research support services and brain stimulation therapy solutions.

Intrinsic Value
Not Available
Back to Top